Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (406) 406
Publication (29) 29
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Patent (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (175) 175
male (119) 119
female (118) 118
cardiac & cardiovascular systems (94) 94
middle aged (94) 94
aged (81) 81
index medicus (75) 75
adult (48) 48
mortality (36) 36
risk factors (36) 36
heart failure (30) 30
prognosis (28) 28
prospective studies (27) 27
follow-up studies (26) 26
medicine, general & internal (26) 26
aged, 80 and over (25) 25
cardiovascular (25) 25
treatment outcome (24) 24
cardiology (23) 23
coronary angiography (23) 23
heart attacks (23) 23
electrocardiography (22) 22
amino acid sequence (21) 21
cardiac patients (21) 21
management (21) 21
abridged index medicus (20) 20
cardiovascular disease (20) 20
switzerland (20) 20
time factors (20) 20
exercise (19) 19
care and treatment (18) 18
myocardial infarction (17) 17
registries (17) 17
acute coronary syndromes (16) 16
acute myocardial-infarction (16) 16
diagnosis (16) 16
studies (16) 16
biomarkers - blood (15) 15
disease (15) 15
exercise test (15) 15
natriuretic peptide, brain - blood (15) 15
therapy (15) 15
animals (14) 14
heart failure - physiopathology (14) 14
analysis (13) 13
patients (13) 13
respiratory system (13) 13
surgery (13) 13
thrombosis (13) 13
acute coronary syndrome (12) 12
biochemistry & molecular biology (12) 12
coronary artery disease (12) 12
coronary vessels (12) 12
echocardiography (12) 12
heart attack (12) 12
myocardial-infarction (12) 12
percutaneous coronary intervention (12) 12
stents (12) 12
transluminal angioplasty (12) 12
trial (12) 12
angioplasty (11) 11
atherosclerosis (11) 11
drug therapy, combination (11) 11
guidelines (11) 11
meteorology & atmospheric sciences (11) 11
multivariate analysis (11) 11
predictive value of tests (11) 11
switzerland - epidemiology (11) 11
association (10) 10
coronary heart disease (10) 10
diabetes (10) 10
heart rate (10) 10
heart-failure (10) 10
natriuretic peptides (10) 10
oxygen consumption (10) 10
retrospective studies (10) 10
risk (10) 10
stroke volume - physiology (10) 10
age (9) 9
drug therapy (9) 9
follow-up (9) 9
heart failure - mortality (9) 9
heart rate - physiology (9) 9
hospital mortality (9) 9
hypertension (9) 9
infarction (9) 9
left-ventricular dysfunction (9) 9
medicine & public health (9) 9
molecular sequence data (9) 9
outcomes (9) 9
610 medicine & health (8) 8
acute coronary syndrome - mortality (8) 8
age factors (8) 8
angiography (8) 8
atrial fibrillation (8) 8
cardiomyopathy (8) 8
clinical trials (8) 8
drug-eluting stents (8) 8
europe (8) 8
exercise test - methods (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2
by Huisman, M.V and Rothman, K.J and Paquette, M and Teutsch, C and Diener, H.C and Dubner, S.J and Halperin, J.L and Ma, C.S and Zint, K and Elsaesser, A and Bartels, D.B and Lip, G.Y and Hemels, M.E and et al and GLORIA-AF Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 7, pp. 777 - 785
BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry... 
registry | oral anticoagulation | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | EUROPEAN-SOCIETY | ATRIAL-FIBRILLATION | ANTITHROMBOTIC TREATMENT | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | Stroke - prevention & control | Prospective Studies | Cross-Sectional Studies | Antithrombins - therapeutic use | Humans | Middle Aged | Atrial Fibrillation - complications | Male | Dabigatran - therapeutic use | Stroke - etiology | Internationality | Fibrinolytic Agents - therapeutic use | Female | Registries | Aged | Hypertension | Heart failure | Cardiac arrhythmia | Anticoagulants | Stroke | Statistical analysis | Cardiovascular disease | Alcohol | Valves | Family medical history | Patients | Demographics | Onsite | Quality | Data collection | Trends | Clinical medicine | Diabetes | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
by Cannon, Christopher P and Blazing, Michael A and Giugliano, Robert P and McCagg, Amy and White, Jennifer A and Theroux, Pierre and Darius, Harald and Lewis, Basil S and Ophuis, Ton Oude and Jukema, J. Wouter and De Ferrari, Gaetano M and Ruzyllo, Witold and De Lucca, Paul and Im, KyungAh and Bohula, Erin A and Reist, Craig and Wiviott, Stephen D and Tershakovec, Andrew M and Musliner, Thomas A and Braunwald, Eugene and Califf, Robert M and IMPROVW-IT Investigators and IMPROVE-IT Investigators
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
by Parving, Hans-Henrik and Brenner, Barry M and McMurray, John J.V and de Zeeuw, Dick and Haffner, Steven M and Solomon, Scott D and Chaturvedi, Nish and Persson, Frederik and Desai, Akshay S and Nicolaides, Maria and Richard, Alexia and Xiang, Zhihua and Brunel, Patrick and Pfeffer, Marc A and ALTITUDE Investigators
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 23, pp. 2204 - 2213
Patients with type 2 diabetes at high risk for cardiovascular disease who were already taking a renin–angiotensin system blocker were randomly assigned to the... 
GLOMERULAR-FILTRATION-RATE | CHRONIC HEART-FAILURE | MEDICINE, GENERAL & INTERNAL | CONVERTING-ENZYME INHIBITORS | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | DOUBLE-BLIND | CARDIOVASCULAR MORTALITY | FOLLOW-UP | SYSTOLIC DYSFUNCTION | BLOOD-PRESSURE | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Patient Dropouts | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Kidney Diseases - epidemiology | Treatment Failure | Amides - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Hypokalemia | Female | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Fumarates - therapeutic use | Kidney Diseases - prevention & control | Amides - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Renin - antagonists & inhibitors | Hyperkalemia - chemically induced | Aged | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Angiotensin Receptor Antagonists - therapeutic use | Myocardial infarction | Women | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Heart attacks | Kidneys | Diabetes mellitus | Cardiovascular disease | Coronary artery disease | Hypotension | Hyperkalemia | Renin | Angiotensin | Renal failure | Diabetes | Kidney diseases | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Heart diseases | Kidney transplantation
Journal Article
Details down arrow
Digital rights down arrow